IP Library Granted Patent US 8,202,532
Granted Patent B2
US 8,202,532 · App. 12/611,830 · Granted Jun 19, 2012

Clay-based hemostatic agents and devices for the delivery thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,202,532
App. No.
12/611,830
Granted
Jun 19, 2012
Kind
B2
Abstract

Disclosed are device for promoting the clotting of blood comprising a clay material and a release agent. In some embodiments, the clay material is disposed within a substrate and the release agent is disposed within a mesh. The release agent can be configured to make direct contact with a bleeding wound when the device is in particle form and the clay material can promote hemostasis.

Claims (39)

1. A hemostatic device, comprising:

a clay material;

a release agent disposed on a discontinuous surface of the device, the release agent being configured to make direct contact with a bleeding wound or a region of a patient near a bleeding wound when the device is applied to the wound; and

wherein the device is configured to allow at least a portion of the clay material to come into contact with blood that has passed through the discontinuous surface.

2. The hemostatic agent of claim 1 , wherein the clay material is selected from the group consisting of attapulgite, bentonite, kaolin, diatomaceous earth, and combinations of the foregoing materials.

3. The hemostatic agent of claim 1 , where the release agent is selected from the group consisting of polyvinyl alcohol, silicone, and gelatinized starch.

4. A device capable of providing a hemostatic effect on a bleeding wound, the device comprising:

a gauze substrate;

a release agent disposed on the gauze substrate, composed of a different material from the gauze substrate; and

a clay material disposed on the gauze substrate;

wherein the device is configured to allow at least a portion of each of the clay material and the release agent to make direct contact with blood when the device is positioned on a bleeding wound.

5. The device of claim 4 , wherein the clay material is selected from the group consisting of attapulgite, bentonite, kaolin, diatomaceous earth, and combinations of the foregoing materials.

6. The device of claim 4 , wherein the gauze substrate is fabricated from a material selected from the group consisting of cotton, silk, wool, plastic, cellulose, oxidized cellulose, rayon, polyester, silk, wool, plastic and combinations of the foregoing.

7. The device of claim 4 , wherein the gauze substrate is flexible to allow the gauze substrate to form to a shape of the bleeding wound and to retrain a shape of the bleeding wound.

8. The device of claim 4 , where the release agent is selected from the group consisting of polyvinyl alcohol, silicone, and gelatinized starch.

9. The device of claim 4 , further comprising a binder to adhere the clay material to the gauze substrate.

10. The device of claim 9 , wherein the binder is selected from the group consisting of chitosan, cellulose, calcium alginate, and polyvinyl alcohol.

11. A device for promoting hemostasis comprising:

a gauze substrate;

a clay material dispersed on the gauze surface; and

a release agent, composed of a different material from the gauze substrate, the release agent being configured to make direct contact with a bleeding wound and the release agent being dispersed on the second gauze surface;

wherein the device is configured to allow at least a portion of the clay material to come into contact with blood that has passed through the release agent.

12. The device of claim 11 , where the clay material is selected from the group consisting of attapulgite, bentonite, kaolin, diatomaceous earth, and combinations of the foregoing materials.

13. A bandage applicable to a bleeding wound, the bandage comprising:

a substrate;

a clay material attached to the substrate;

a mesh defined by a plurality of members arranged to define openings, the openings being dimensioned to accommodate the flow of blood therethrough; and

a release agent composed of a different material from the substrate, the release agent being attached to the mesh.

14. The bandage of claim 13 , where the clay material is selected from the group consisting of attapulgite, bentonite, kaolin, diatomaceous earth, and combinations of the foregoing materials.

15. The bandage of claim 13 , wherein the substrate is fabricated from a material selected from the group consisting of cotton, rayon/polyester cellulose blends, cellulose, paper, silk, wool, plastic, and combinations of the foregoing.

16. A device for promoting hemostasis, comprising:

a hemostatic material in particle form;

a release agent positioned on the device so as to make direct contact with a bleeding wound when the device is applied to a wound;

a receptacle for retaining the hemostatic material and the release agent therein, at least a portion of the receptacle being defined by a mesh having openings therein; and

wherein the device is configured to allow at least a portion of the hemostatic material to come into contact with blood that has passed through the release agent.

17. The device for promoting hemostasis of claim 16 , wherein the mesh is flexible.

18. The device for promoting hemostasis of claim 16 wherein the hemostatic material is attapulgite, bentonite, kaolin, diatomaceous earth, and combinations of the foregoing materials.

19. The device for promoting hemostasis of claim 16 where the release agent is selected from the group consisting of polyvinyl alcohol, silicone, and gelatinized starch.

20. The receptacle of claim 16 , wherein at least a portion of the receptacle comprises at least one material selected from the group consisting of oxidized cellulose, collagen, gelatinized starches, and guar gum.

Assignments (19)
SECURITY INTEREST Recorded Mar 1, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066723/0376 →
CHANGE OF NAME Recorded Feb 29, 2024
From: TELEFLEX TECHNOLOGIES LLC
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066836/0737 →
MERGER Recorded Feb 29, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: TELEFLEX TECHNOLOGIES LLC
Reel/Frame 066707/0695 →
MERGER Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: TELEFLEX TECHNOLOGIES LLC
Reel/Frame 066621/0946 →
CHANGE OF NAME Recorded Feb 16, 2024
From: TELEFLEX TECHNOLOGIES LLC
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066621/0882 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066616/0701 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066434/0248 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2022
From: Z-MEDICA, LLC
To: TELEFLEX LIFE SCIENCES LIMITED
Reel/Frame 058740/0387 →
SECURITY INTEREST Recorded Mar 2, 2021
From: Z-MEDICA, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 055455/0099 →
RELEASE OF SECURITY INTEREST Recorded Jan 6, 2021
From: TWIN BROOK CAPITAL PARTNERS, LLC
To: Z-MEDICA, LLC
Reel/Frame 054832/0770 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INADVERTENT OMISSION OF APPLICATION NO. 14/185873 FROM THE COVER SHEET PREVIOUSLY RECORDED AT REEL: 044151 FRAME: 0282. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 22, 2020
From: MADISON CAPITAL FUNDING LLC
To: Z-MEDICA, LLC
Reel/Frame 054882/0904 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 035308/0704 Recorded Oct 9, 2017
From: MADISON CAPITAL FUNDING LLC
To: Z-MEDICA, LLC
Reel/Frame 044151/0282 →
SECURITY INTEREST Recorded Sep 29, 2017
From: Z-MEDICA, LLC
To: TWIN BROOK CAPITAL PARTNERS, LLC, AS AGENT
Reel/Frame 043738/0690 →
RELEASE AND REASSIGNMENT Recorded Apr 9, 2015
From: ABACUS FINANCE GROUP, LLC
To: Z-MEDICA, LLC
Reel/Frame 035389/0800 →
MERGER Recorded Apr 1, 2015
From: Z-MEDICA CORPORATION
To: Z-MEDICA, LLC
Reel/Frame 035353/0423 →
SECURITY INTEREST Recorded Apr 1, 2015
From: Z-MEDICA, LLC
To: MADISON CAPITAL FUNDING LLC, AS AGENT
Reel/Frame 035308/0704 →
SECURITY AGREEMENT Recorded Sep 6, 2012
From: Z-MEDICA, LLC
To: ABACUS FINANCE GROUP, LLC
Reel/Frame 028917/0898 →
MERGER Recorded Sep 4, 2012
From: Z-MEDICA CORPORATION
To: Z-MEDICA, LLC
Reel/Frame 028896/0108 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2010
From: HUEY, RAYMOND J.; LO, DENNY; BURNS, DANIEL J.; BASADONNA, GIACOMO; HURSEY, FRANCIS X.
To: Z-MEDICA CORPORATION
Reel/Frame 024440/0017 →